Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 8.48 | N/A |
| PEG Ratio (TTM) | -3.66 | N/A |
| P/S Ratio (TTM) | 2.55 | N/A |
| P/B Ratio (TTM) | 1.54 | N/A |
| P/FCF Ratio (TTM) | 9.45 | N/A |
| Price to 5YR AVG Earnings Ratio | 12.12 | N/A |
| Price to 5YR AVG FCF Ratio | 9.39 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.98% | N/A |
| ROE (TTM) | 19.01% | N/A |
| Net Profit Margin (TTM) | 29.89% | N/A |
| ROIC 5YR AVG | -306.55% | N/A |
Growth (63%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -2.23% | 12.51% | 19.16% |
| Revenue | 5.73% | 5.91% | 11.49% |
| Net Income | -3.26% | 12.04% | 17.57% |
| Cash Flow | 3,024.02% | 7.51% | 12.94% |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.32 | N/A |
| Quick Ratio (TTM) | 0.32 | N/A |
| D/E Ratio (TTM) | 0.20 | N/A |
| Interest Coverage (TTM) | 0.82 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 0.20 | N/A |
| LTL to 5YR AVG FCF | 1.36 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.30% | N/A |